sumatriptan succinate

sumatriptan succinate (SUMATRIPTAN SUCCINATE) is an FDA-listed pharmaceutical active ingredient. Associated with Tonix Pharmaceuticals Holding. Route of administration: iontophoresis. Current US regulatory status: approved.

SUMATRIPTAN SUCCINATE is a marketed brand name for sumatriptan succinate. Check FDA Drugs@FDA for the current US label holder and prescribing information.

sumatriptan succinate has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.